One-year outcome of two different initial doses of intravitreal ranibizumab for myopic choroidal neovascularization

被引：0
|
作者：
Kung, Ya-Hsin [1 ,2 ]
Wu, Tsung-Tien [1 ,2 ]
机构：
[1] Kaohsiung Vet Gen Hosp, Ophthalmol, Kaohsiung, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
453 choroid: neovascularization; 605; myopia; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2791
引用
收藏
页数：2
相关论文
共 50 条
  • [1] One-year outcome of two different initial dosing regimens of intravitreal ranibizumab for myopic choroidal neovascularization
    Kung, Ya-Hsin
    Wu, Tsung-Tien
    Huang, Ya-Hui
    [J]. ACTA OPHTHALMOLOGICA, 2014, 92 (08) : e615 - e620
  • [2] One-Year Outcome of Intravitreal Injection of Ranibizumab Biosimilar for Myopic Choroidal Neovascularization in Japanese Patients
    Tomita, Mami
    Yamamoto, Manabu
    Hirayama, Kumiko
    Kyo, Akika
    Misawa, Norihiko
    Kinari, Gen
    Kohno, Takeya
    Honda, Shigeru
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [3] Two-Year Outcome of Intravitreal Injections of Ranibizumab for Myopic Choroidal Neovascularization
    Wu, Tsung-Tien
    Kung, Ya-Hsin
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (10) : 837 - 841
  • [4] Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses
    Ruiz-Moreno, Jose M.
    Montero, Javier A.
    Amat-Peral, Pedro
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (04) : 595 - 599
  • [5] Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses
    Jose M. Ruiz-Moreno
    Javier A. Montero
    Pedro Amat-Peral
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 595 - 599
  • [6] Two-Year Results of Intravitreal Ranibizumab in Patients with Myopic Choroidal Neovascularization
    Shchuko, Andrey G.
    Zaytseva, Natalya V.
    Zlobin, Igor V.
    [J]. OPHTHALMOLOGICA, 2014, 232 : 51 - 51
  • [7] The Evaluation of a Two-Year Outcome of Intravitreal Conbercept versus Ranibizumab for Pathological Myopic Choroidal Neovascularization
    Chen, Cong
    Yan, Ming
    Huang, Zhen
    Song, Yan-Ping
    [J]. CURRENT EYE RESEARCH, 2020, 45 (11) : 1415 - 1421
  • [8] Single intravitreal ranibizumab for myopic choroidal neovascularization
    Nor-Masniwati, Saidin
    Shatriah, Ismail
    Zunaina, Embong
    [J]. CLINICAL OPHTHALMOLOGY, 2011, 5 : 1079 - 1082
  • [9] Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results-A Retrospective, Comparative Study
    Erden, Burak
    Bolukbasi, Selim
    Bas, Emine
    Cakir, Akin
    [J]. JOURNAL OF OPHTHALMOLOGY, 2019, 2019
  • [10] Retinoschisis and intravitreal ranibizumab treatment for myopic choroidal neovascularization
    Huang Jianfeng
    Chen Tong
    Lu Yingyi
    Long Li
    Dai Hong
    [J]. 中华医学杂志(英文版), 2014, (11) : 2053 - 2057
12345